- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sandu Pharmaceuticals is offering a special window for physical shareholders to resubmit transfer requests previously rejected before April 2019, which will now be processed only in dematerialized form. Concurrently, the company has launched the "Saksham Niveshak" campaign to assist shareholders in updating their KYC details and claiming unpaid dividends, preventing these assets from transferring to the Investor Education and Protection Authority. Separately, an e-voting postal ballot is underway for shareholders to approve the re-classification of M/s Akshath Finvest and Properties Private Limited from the promoter group to the public category, impacting the company's ownership structure.